Koshinski Asset Management
NVAX icon

Koshinski Asset Management’s Novavax NVAX Stock Holding History

Koshinski Asset Management’s Portfolio NVAX Stock Details NVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-92
Closed -$6.78K – 1505
2022
Q1 		$6.78K Buy
+92
New +$8.2K ﹤0.01% 1718
2021
Q4 		– Sell
-10
Closed -$2.07K – 2212
2021
Q3 		$2.07K Buy
+10
New +$2.2K ﹤0.01% 2013

Other funds holding NVAX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Voloridge Investment Management
Voloridge Investment Management Jupiter, Florida $25B AUM 28.08% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Koshinski Asset Management's NVAX Position: Q2 2022 in Review

Koshinski Asset Management sold out of Novavax (NVAX) in Q2 2022, closing a stake of 92 shares — an estimated $6.78K sold.

Koshinski Asset Management first reported a position in NVAX in Q3 2021 and held it in 2 quarters. The position peaked at $6.78K in Q1 2022. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.

  • Koshinski Asset Management reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
  • Koshinski Asset Management sold 92 Novavax shares in Q2 2022, an estimated $6.78K.
  • Koshinski Asset Management first reported a position in Novavax in Q3 2021 and held it in 2 quarters.
  • Koshinski Asset Management's Novavax position peaked at $6.78K in Q1 2022.
  • 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.

Based on Koshinski Asset Management's 13F filing for Q2 2022, filed 12 Jul 2022.